Avocates et Avocats Iliana Djagova

Iliana Djagova

Associée
lic. iur., LL.M., Avocate

vCard LinkedIn

Site

Zurich

Contact

Téléphone direct: +41 58 658 56 98
iliana.djagova@walderwyss.com

Curriculum vitae

Télécharger le PDF

Domaines d'activité: Corporate / M&A Contrats commerciaux Marchés des capitaux

Iliana Djagova is a partner in the Corporate/M&A team of Walder Wyss. She has extensive experience advising on complex domestic and cross-border M&A transactions, growth equity financings and late-stage investments. She regularly acts for strategic and financial investors, including private equity firms, on both the buy-side and sell-side. Iliana Djagova also advises companies and shareholders throughout all stages of their lifecycle, with a particular focus on growth-stage and exit transactions. In addition, she counsels private and listed companies, as well as their shareholders, on corporate governance and general corporate and commercial law matters.

Prior to joining Walder Wyss in 2023, Iliana Djagova spent eight years at another leading Swiss law firm, advising on high-profile M&A and private equity transactions. In 2015/16 she further broadened her international experience at Willkie Farr & Gallagher LLP in New York, USA.

Iliana Djagova studied law at the University of Geneva and Zurich (lic. iur., 2010) and the University of California, Berkeley (LL.M., 2015). She was admitted to the Zurich Bar in 2013 and to the New York Bar in 2018.

Iliana Djagova’s professional languages are German and English. She also speaks Bulgarian and French.

IFLR1000 Rankings 2026: Walder Wyss recognised as a top-tier law firm

29 septembre 2026

Callista Group acquires leading e-bike retailer M-Way from TVS Motor Company

9 juillet 2026

Biotech Company CRISPR Therapeutics (NASDAQ) issued USD 600M Convertible Notes

18 mars 2026

SIS Medical AG – Investment by Claret Capital Partners

16 janvier 2026

Promotions chez Walder Wyss

5 janvier 2026

Tender offer for u-blox successfully completed

27 novembre 2025

Swiss MedTech company Distalmotion SA closes USD 150m Series G Financing Round

20 novembre 2025

IFLR 1000 Rankings 2025 - Walder Wyss as a top-performing law firm ranked

10 octobre 2025

Corient acquires Stonehage Fleming and Stanhope Capital

4 septembre 2025

Public Tender Offer for SIX-listed u-blox

18 août 2025

SoftwareOne successfully completes its tender offer for Crayon

3 juillet 2025

Walder Wyss advised Novo Holdings on the acquisition of Catalent

30 janvier 2025

SoftwareOne to launch tender offer for all outstanding Crayon shares

19 décembre 2024

Alentis Therapeutics Raises USD 181.4m in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors

12 novembre 2024

Boehringer Ingelheim acquires veterinary therapeutic vaccines developer Saiba Animal Health

10 septembre 2024

Swixx Biopharma acquires Biopas to enter Latin America

28 juin 2024

SOPHiA GENETICS SA closed secured term loan financing

8 mai 2024

Walder Wyss advised CRISPR Therapeutics (NASDAQ) on USD 280 Million Equity Issuance

16 février 2024

Walder Wyss advised Nasdaq listed Altamira Therapeutics in its sale of majority stake in Altamira Medica

5 décembre 2023

Convertibles and Warrants – Corporate and Tax Law Pitfalls in Practice

Switzerland – Corporate Governance Laws and Regulations 2026

23 juillet 2026 | par Hans-Jakob Diem et Iliana Djagova | dans: «International Comparative Legal Guides – Corporate Governance Laws and Regulations 2026» | Online-Publikation

Switzerland: A Corporate/M&A Overview

13 février 2026 | par Hans-Jakob Diem, Alex Nikitine et Iliana Djagova | dans: «Chambers Global 2026» | Online-Publikation

Basel Commentary on art. 659-659b and 783 CO re Treasury Shares (Online Update)

31 octobre 2025 | par Iliana Djagova et Sarah Vettiger | dans: in: Rolf Watter/Hans-Ueli Vogt (Editor[s]), «Commentary on art. 659-659b and 783 CO re Treasury Shares (Online Update)» | Basler Kommentar zum Obligationenrecht II | Monographien